Drug Marketing Techniques Appear To Flout Patients' Safety Norms

A report has cast doubts on the manner in which drugs are released into the market, faster than ever before, raising concerns about patients' safety.

Author David Kao, from the University of Colorado Health Sciences Center, says that the pressure on drug regulatory bodies to make new medicines available more quickly has raised fresh concerns about patients' safety.

Americans Get Least Value For Money In Healthcare
Studies show that the United States, which has the most expensive health system in the world, ranks last among other major rich countries for quality, access and efficiency of healthcare.

He reviewed trends in drug approval times in the U.S., and came up with suggestions as to how marketing techniques could be used to improve the way new medicines were monitored.

Publishing his report in the online edition of the British Medical Journal (BMJ), he has highlighted the fact that marketing techniques these days are so sophisticated that once a drug has been approved, the products can be released on websites within 90 minutes.

He even points out how 188 million patients had been targeted by the marketing campaign within 14 days after Merck's new treatment for high blood sugar levels, sitagliptin, was approved.

IT Delays Putting Patient Safety at Risk, Say Senior NHS Staff
Senior NHS staff support IT modernization but say that continuing delays are putting patient safety at risk, according to a study published on bmj.com today.

Kao thinks that a large number of patients may be exposed to unknown risks if people try any new medicine so quickly.

The reviewer also says that regulatory agencies often depend on drug companies for funding, and collect fees so as to hire staff to review new medicines more quickly.

Patient Safety Should Be Top Priority While Prescribing Medications: AMA
Doctors must maintain sole responsibility for prescribing medication to patients, AMA President, Dr Rosanna Capolingua said today.

He recommends improvement in the systems for reporting adverse drug reactions, and the use of the very same effective drug marketing techniques to do so.

Kao says that U.S. laws already compel TV adverts to instruct patients experiencing negative side effects to report their symptoms to the FDA, and this could be expanded to include campaigns dedicated to drug safety monitoring.

Medical Teams Are Key to Patient Safety
Medical teams – not individuals – are critical to the prevention of catheter-related bloodstream infections, as well as for the overall health, safety, and welfare of patients

According to him, the only drug monitoring system that will minimise unknown risks must involve all the key players in healthcare, including doctors, regulatory bodies, drug companies and patients.

Source-ANI
SAV/SK